Background: The previous first-in-human study established the preliminary safety and effectiveness of the novel thin-strut iron bioresorbable scaffold (IBS). The current study aims to directly compare the imaging and physiological efficacy, and clinical outcomes of IBS with contemporary metallic drug-eluting stents (DES).
Methods: A total of 518 patients were randomly allocated to treatment with IBS (257 patients) or metallic DES (261 patients) from 36 centers in China. The study is powered to test noninferiority of the IBS compared with the metallic everolimus-eluting stent in terms of the primary endpoint of in-segment late lumen loss at 2 years, and major secondary endpoints including 2-year quantitative flow ratio and cross-sectional mean flow area measured by optical coherence tomography (OCT) (limited to the OCT subgroup, 25 patients in each group).
Conclusion: This will be the first powered randomized trial investigating the safety and efficacy of the novel thin-strut IBS compared to a contemporary metallic DES. The findings will provide valuable evidence for future research of this kind and the application of metallic bioresorbable scaffolds.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ahj.2024.05.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bioresorbable vascular metallic scaffolds: Current status and research trends.
Curr Opin Biomed Eng
December 2022
Department of Biomedical Engineering, Michigan Technological University, Houghton, MI, 49931, USA.
To combat the long-term side effects associated with present-generation drug-eluting stents and provide opportunities for repeat scaffolding of plaqued arteries and treatment of coarctation of the aorta in infants and children, a new generation of bioresorbable stents has been introduced. Stents made of bioresorbable materials are corroded and absorbed by the body after completing their task as vascular scaffolding, allowing the stented arteries to restore their normal function. The concept is achieved by engineering stents that retain mechanical properties and integrity for at least 6-12 months before being broken down, metabolized, and harmlessly excreted by the body, leaving the treated vessel with a healthy endothelium, normal vasomotion, and free of the implant.
View Article and Find Full Text PDFA Review of Additive Manufacturing of Biodegradable Fe and Zn Alloys for Medical Implants Using Laser Powder Bed Fusion (LPBF).
Materials (Basel)
December 2024
Department of Applied Mathematics, Materials Science and Engineering and Electronic Technology, Escuela Superior de Ciencias Experimentales y Tecnología (ESCET), Universidad Rey Juan Carlos, C/Tulipán s/n, 28933 Móstoles, Spain.
This review explores the advancements in additive manufacturing (AM) of biodegradable iron (Fe) and zinc (Zn) alloys, focusing on their potential for medical implants, particularly in vascular and bone applications. Fe alloys are noted for their superior mechanical properties and biocompatibility but exhibit a slow corrosion rate, limiting their biodegradability. Strategies such as alloying with manganese (Mn) and optimizing microstructure via laser powder bed fusion (LPBF) have been employed to increase Fe's corrosion rate and mechanical performance.
View Article and Find Full Text PDFPerformance evaluation of a low-cost Ti-Mo-Fe (TMF8) as a replacement for Ti-6Al-4V for internal fixation implants used in mandibular angular fractures: a finite element analysis study.
J Mater Sci Mater Med
November 2024
Department of Materials Science and Engineering, Egypt-Japan University of Science and Technology, New Borg El-Arab City, Alexandria, Egypt.
Stainless steel and titanium-based alloys have been the gold standard when it comes to permanent implants and magnesium-based alloys have been the best option for bioresorbable alloys. Ti-6Al-4V, Ti-64, with its 110 GPa Young's Modulus is the most commonly employed alloy to manufacture biomedical implants used for treatment of fractures of skeleton. Recently, researchers have developed a new low-cost and toxic Vanadium-free alternative to this alloy, Ti-3Mo-0.
View Article and Find Full Text PDFPreclinical evaluation of the sirolimus-eluting iron bioresorbable scaffold in canine below-the-knee artery.
Int J Cardiol
February 2025
Department of Vascular and Endovascular Surgery, First Medical Center of Chinese PLA General Hospital, Beijing 100853, China. Electronic address:
Article Synopsis
- This study investigates the effectiveness of bioresorbable scaffolds (IBS) versus everolimus-eluting stents (EES) for treating below-the-knee arterial disease in dogs, focusing on their support performance and effects on tissue.
- Both types of implants were successfully used, showing similar levels of arterial narrowing within the first six months, but the IBS scaffold exhibited gradual corrosion over time.
- Overall, the findings indicate that the IBS is comparable to EES in terms of support and tissue response within 6 months, while demonstrating a manageable corrosion profile over a year.
Coronary bioresorbable metallic stents: Advancements and future perspectives.
J Cardiol
August 2024
Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China. Electronic address:
Article Synopsis
- Percutaneous coronary intervention is a key treatment for coronary artery disease, especially for heart attacks, but traditional metallic stents can cause complications that bioresorbable stents aim to mitigate.
- Bioresorbable polymeric stents face challenges like low mechanical strength, leading to thrombosis and inflammation, which has prompted interest in using bioresorbable metals like iron, zinc, and magnesium instead.
- Early studies show promise for zinc and magnesium stents in terms of safety and absorption rates, but more extensive human clinical trials are necessary to confirm their effectiveness and address current limitations.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!